{"id":8322,"date":"2026-01-23T20:29:07","date_gmt":"2026-01-23T12:29:07","guid":{"rendered":"https:\/\/ozellemed.com\/?p=8322"},"modified":"2026-01-31T00:45:00","modified_gmt":"2026-01-30T16:45:00","slug":"fda-510k-and-ce-mark-ivdr-for-cbc-analyzers-two-distinct-regulatory-systems-how-to-navigate-both","status":"publish","type":"post","link":"https:\/\/ozellemed.com\/pt\/fda-510k-and-ce-mark-ivdr-for-cbc-analyzers-two-distinct-regulatory-systems-how-to-navigate-both\/","title":{"rendered":"FDA 510(k) e marca CE (IVDR) para analisadores de CBC: Dois sistemas regulamentares distintos - como navegar em ambos"},"content":{"rendered":"<p>A aprova\u00e7\u00e3o regulamentar \u00e9 essencial, mas estruturalmente diferente nos EUA e na UE para <a href=\"https:\/\/ozellemed.com\/pt\/auto-hematology-analyzer\/\">Fornecedores de analisadores de hemograma<\/a>. A via 510(k) da FDA e o sistema de marca\u00e7\u00e3o CE IVDR da UE utilizam arquitecturas processuais, requisitos de provas e modelos de governa\u00e7\u00e3o distintos - e n\u00e3o apenas velocidades diferentes para o mesmo objetivo.<\/p>\n\n\n\n<p>A FDA 510(k) consegue a aprova\u00e7\u00e3o atrav\u00e9s da equival\u00eancia predicado-dispositivo em 4-12 meses (se existirem predicados fortes). A marca\u00e7\u00e3o CE ao abrigo do IVDR requer a avalia\u00e7\u00e3o da conformidade do Organismo Notificado em cinco m\u00f3dulos estratificados por risco (Classe A-D) com prazos de 12-18 meses, mas enfatiza a revis\u00e3o sistem\u00e1tica de provas cl\u00ednicas em vez da compara\u00e7\u00e3o de predicados. Cada sistema tem vantagens distintas, dependendo dos predicados dispon\u00edveis, do local de fabrico e dos dados cl\u00ednicos.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-the-three-regulatory-pathways-at-a-glance\">As tr\u00eas vias de regulamenta\u00e7\u00e3o num relance<\/h2>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" width=\"1024\" height=\"576\" src=\"https:\/\/ozellemed.com\/wp-content\/uploads\/2025\/09\/gqh3yfteurm-1024x576.jpg\" alt=\"\" class=\"wp-image-7537\" srcset=\"https:\/\/ozellemed.com\/wp-content\/uploads\/2025\/09\/gqh3yfteurm-1024x576.jpg 1024w, https:\/\/ozellemed.com\/wp-content\/uploads\/2025\/09\/gqh3yfteurm-300x169.jpg 300w, https:\/\/ozellemed.com\/wp-content\/uploads\/2025\/09\/gqh3yfteurm-768x432.jpg 768w, https:\/\/ozellemed.com\/wp-content\/uploads\/2025\/09\/gqh3yfteurm-18x10.jpg 18w, https:\/\/ozellemed.com\/wp-content\/uploads\/2025\/09\/gqh3yfteurm.jpg 1280w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-fda-510-k-pathway-usa\">Via 510(k) da FDA (EUA)<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Classifica\u00e7\u00e3o: Dispositivos m\u00e9dicos da classe II (risco moderado)<\/li>\n\n\n\n<li>Prazo: objetivo de 90 dias FDA; mundo real: 4-12 meses de calend\u00e1rio (m\u00e9dia de 164 dias)<\/li>\n\n\n\n<li>Cost: $100,000\u2013$500,000<\/li>\n\n\n\n<li>Requisito-chave: Dispositivo de refer\u00eancia (substancialmente equivalente ao analisador aprovado)<\/li>\n\n\n\n<li>Provas exigidas: Ensaios de engenharia\/bancada, biocompatibilidade, valida\u00e7\u00e3o de software<\/li>\n<\/ul>\n\n\n\n<p>A via da FDA baseia-se numa estrat\u00e9gia de dispositivo predicado. Ao identificar um analisador aprovado substancialmente equivalente ao seu produto, os fabricantes podem evitar ensaios cl\u00ednicos dispendiosos. Os predicados fortes incluem a s\u00e9rie XN da Sysmex, o DxH da Beckman Coulter, o CELL-DYN da Abbott e o BC-6800 da Mindray. A sele\u00e7\u00e3o do predicado \u00e9 cr\u00edtica - uma sele\u00e7\u00e3o errada resulta numa Recusa de Aceita\u00e7\u00e3o (RTA) no Dia 15, atrasando todo o cronograma.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-ce-marking-ivdr-pathway-eu\">Via de marca\u00e7\u00e3o CE (IVDR) (UE)<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Classifica\u00e7\u00e3o: Classe B-D (sistema IVDR; classifica\u00e7\u00e3o de risco mais elevada do que o IVDD anterior)<\/li>\n\n\n\n<li>Prazo: 12-18 meses em m\u00e9dia (avalia\u00e7\u00e3o do organismo notificado 11-18 meses)<\/li>\n\n\n\n<li>Custo: 15 000 a 50 000 euros (taxas do organismo notificado + documenta\u00e7\u00e3o)<\/li>\n\n\n\n<li>Requisito essencial: Documenta\u00e7\u00e3o t\u00e9cnica + gest\u00e3o dos riscos + avalia\u00e7\u00e3o cl\u00ednica (anexo XIV da Diretiva IVDR)<\/li>\n\n\n\n<li>Evid\u00eancias necess\u00e1rias: Revis\u00e3o sistem\u00e1tica da literatura + avalia\u00e7\u00e3o dos riscos e benef\u00edcios<\/li>\n<\/ul>\n\n\n\n<p>De acordo com o Anexo VIII do RIV, <a href=\"https:\/\/ozellemed.com\/pt\/multi-functional-analyzer\/\">Analisadores de hemograma<\/a> Os dispositivos de rastreio de doen\u00e7as s\u00e3o normalmente classificados como de classe B ou de classe C com base na utiliza\u00e7\u00e3o prevista. A classe C aplica-se quando os dispositivos reivindicam a capacidade de detetar marcadores de infe\u00e7\u00e3o ou de malignidade; a classe D \u00e9 excecional e limita-se ao rastreio da seguran\u00e7a dos dadores de sangue. A classifica\u00e7\u00e3o baseia-se no risco, de acordo com o Anexo VIII, e n\u00e3o \u00e9 determinada por nomes de doen\u00e7as. Ao contr\u00e1rio da via predicada da FDA, a marca\u00e7\u00e3o CE exige uma documenta\u00e7\u00e3o t\u00e9cnica exaustiva e uma avalia\u00e7\u00e3o cl\u00ednica sistem\u00e1tica, de acordo com o Anexo XIV da IVDR. Esta hierarquia de provas formais revela-se frequentemente mais rigorosa do que os requisitos da FDA 510(k).<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-detailed-fda-510-k-pathway\">Percurso detalhado da FDA 510(k)<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-the-510-k-process-four-phases\">O processo 510(k): Quatro fases<\/h3>\n\n\n\n<p>Fase 1: Pr\u00e9-apresenta\u00e7\u00e3o (meses 0-2)<\/p>\n\n\n\n<p>Identificar um dispositivo predicado forte e desenvolver um pacote de apresenta\u00e7\u00e3o que inclua documenta\u00e7\u00e3o t\u00e9cnica, compara\u00e7\u00e3o de predicados e alega\u00e7\u00f5es de seguran\u00e7a\/desempenho. Realizar testes de biocompatibilidade de acordo com a norma ISO 10993 e preparar a documenta\u00e7\u00e3o do software com matrizes de valida\u00e7\u00e3o e avalia\u00e7\u00e3o da ciberseguran\u00e7a. Fator cr\u00edtico de sucesso: Predicado errado = Recusa de aceita\u00e7\u00e3o no 15\u00ba dia.<\/p>\n\n\n\n<p>Fase 2: Submiss\u00e3o e revis\u00e3o da aceita\u00e7\u00e3o (meses 2-3)<\/p>\n\n\n\n<p>Apresentar atrav\u00e9s do eSTAR (sistema eletr\u00f3nico da FDA). A FDA efectua uma an\u00e1lise de aceita\u00e7\u00e3o no prazo de 15 dias de calend\u00e1rio e emite uma carta de confirma\u00e7\u00e3o com a data de rece\u00e7\u00e3o e o n\u00famero 510(k). Se for detectada uma defici\u00eancia: \u00c9 emitida uma carta de reten\u00e7\u00e3o; 180 dias de calend\u00e1rio para corrigir a situa\u00e7\u00e3o ou a apresenta\u00e7\u00e3o \u00e9 retirada.<\/p>\n\n\n\n<p>Fase 3: Revis\u00e3o substantiva (Dias 16-90)<\/p>\n\n\n\n<p>O revisor principal efectua uma an\u00e1lise t\u00e9cnica completa da seguran\u00e7a\/desempenho. Normalmente, o prazo de revis\u00e3o substantiva \u00e9 de 60 dias. Os pedidos de informa\u00e7\u00f5es adicionais (IA) interrompem o prazo de 90 dias. Cada ciclo de IA acrescenta 30-60 dias de calend\u00e1rio. Este prazo alargado explica a m\u00e9dia real de 164 dias de calend\u00e1rio, incluindo todas as pausas.<\/p>\n\n\n\n<p>Fase 4: Decis\u00e3o da FDA (objetivo do dia 90)<\/p>\n\n\n\n<p>Determina\u00e7\u00e3o de substancialmente equivalente (SE) = Apuramento \u2713<\/p>\n\n\n\n<p>N\u00e3o substancialmente equivalente (NSE) = \u00c9 necess\u00e1ria uma reclassifica\u00e7\u00e3o, dados adicionais ou uma nova conce\u00e7\u00e3o<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-fda-510-k-cost-breakdown\">Reparti\u00e7\u00e3o dos custos FDA 510(k)<\/h3>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td class=\"has-text-align-left\" data-align=\"left\">Componente de custo<\/td><td class=\"has-text-align-left\" data-align=\"left\">Gama<\/td><td class=\"has-text-align-left\" data-align=\"left\">Notas<\/td><\/tr><tr><td>Taxa de utiliza\u00e7\u00e3o da FDA<\/td><td>$30,000\u2013$44,000<\/td><td>Fixo; exigido aquando da apresenta\u00e7\u00e3o<\/td><\/tr><tr><td>Documenta\u00e7\u00e3o t\u00e9cnica<\/td><td>$30,000\u2013$100,000<\/td><td>Revis\u00e3o da literatura, an\u00e1lise de risco, hist\u00f3ria da conce\u00e7\u00e3o<\/td><\/tr><tr><td>Testes e valida\u00e7\u00e3o<\/td><td>$20,000\u2013$150,000<\/td><td>Biocompatibilidade, software, testes de bancada<\/td><\/tr><tr><td>Consultoria em mat\u00e9ria de regulamenta\u00e7\u00e3o<\/td><td>$30,000\u2013$100,000<\/td><td>Sele\u00e7\u00e3o de predicados, estrat\u00e9gia FDA, intera\u00e7\u00f5es<\/td><\/tr><tr><td>Estudo cl\u00ednico (se necess\u00e1rio)<\/td><td>$50,000\u2013$300,000+<\/td><td>Evitar atrav\u00e9s de uma estrat\u00e9gia de predicado forte<\/td><\/tr><tr><td>Total Mediana<\/td><td>$100,000\u2013$500,000+<\/td><td>-<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p>Estrat\u00e9gia de otimiza\u00e7\u00e3o de custos: Evitar ensaios cl\u00ednicos selecionando um dispositivo predicado forte; aproveitar os testes de bancada e a literatura publicada para apoiar as reivindica\u00e7\u00f5es. As taxas de sucesso no mundo real mostram que ~90% de 510(k)s alcan\u00e7am a determina\u00e7\u00e3o SE de acordo com os objectivos MDUFA V da FDA, com ~40-50% a receberem pelo menos um ciclo de pedido de IA que prolonga o prazo em 30-90 dias.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Percurso pormenorizado da marca\u00e7\u00e3o CE (IVDR)<\/h2>\n\n\n\n<figure class=\"wp-block-image size-full\"><img decoding=\"async\" width=\"720\" height=\"476\" src=\"https:\/\/ozellemed.com\/wp-content\/uploads\/2025\/11\/10.png\" alt=\"Guia do comprador do analisador hematol\u00f3gico de hemograma: Como escolher o analisador certo\" class=\"wp-image-8017\" srcset=\"https:\/\/ozellemed.com\/wp-content\/uploads\/2025\/11\/10.png 720w, https:\/\/ozellemed.com\/wp-content\/uploads\/2025\/11\/10-300x198.png 300w, https:\/\/ozellemed.com\/wp-content\/uploads\/2025\/11\/10-18x12.png 18w\" sizes=\"(max-width: 720px) 100vw, 720px\" \/><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\">Processo de marca\u00e7\u00e3o CE: Quatro fases<\/h3>\n\n\n\n<p>Fase 1: Prepara\u00e7\u00e3o da documenta\u00e7\u00e3o t\u00e9cnica (meses 0-3)<\/p>\n\n\n\n<p>Compilar a documenta\u00e7\u00e3o t\u00e9cnica de acordo com os anexos II e III da Diretiva IVDR. Desenvolver um plano de gest\u00e3o dos riscos (ISO 13485 QMS). Preparar a avalia\u00e7\u00e3o cl\u00ednica de acordo com o Anexo XIV da Diretiva IVDR, incluindo uma an\u00e1lise sistem\u00e1tica da literatura e dados de desempenho cl\u00ednico. Atribuir um Identificador \u00danico do Dispositivo (UDI). Identificar o organismo notificado com capacidade dispon\u00edvel - atualmente, a capacidade \u00e9 limitada, com atrasos de mais de 18 meses.<\/p>\n\n\n\n<p>Fase 2: Apresenta\u00e7\u00e3o ao Organismo Notificado (Meses 3-6)<\/p>\n\n\n\n<p>Apresenta\u00e7\u00e3o do pedido de avalia\u00e7\u00e3o da conformidade ao organismo notificado. Pagamento de taxas (~15 000 a 50 000 euros, consoante a complexidade). O organismo notificado efectua o exame de aceita\u00e7\u00e3o. Cr\u00edtico: Os requerentes devem assinar o acordo at\u00e9 26 de setembro de 2024.<\/p>\n\n\n\n<p>Fase 3: Avalia\u00e7\u00e3o do organismo notificado (meses 6-18)<\/p>\n\n\n\n<p>Certifica\u00e7\u00e3o do SGQ da UE (auditoria da gest\u00e3o da qualidade): 11-18 meses<\/p>\n\n\n\n<p>Avalia\u00e7\u00e3o da documenta\u00e7\u00e3o t\u00e9cnica da UE (TDA): 12-18 meses (varia consoante o Organismo Notificado)<\/p>\n\n\n\n<p>Os pedidos de informa\u00e7\u00f5es adicionais (ciclos CAR\/OBN) podem prolongar o prazo de 3 a 6 meses por ciclo<\/p>\n\n\n\n<p>A capacidade do Organismo Notificado continua a ser um constrangimento significativo; a partir de 2025, aproximadamente 19 Organismos Notificados foram designados ao abrigo do IVDR, mas a capacidade funcional varia consoante o volume de trabalho de avalia\u00e7\u00e3o e a classe do dispositivo. Os prazos actuais para a avalia\u00e7\u00e3o do SGQ da UE s\u00e3o, em m\u00e9dia, de 11 a 18 meses, pelo que os fabricantes s\u00e3o aconselhados a contactar atempadamente o Organismo Notificado que escolheram.<\/p>\n\n\n\n<p>Fase 4: Emiss\u00e3o da marca CE (meses 18-24)<\/p>\n\n\n\n<p>O organismo notificado emite certificados ap\u00f3s uma avalia\u00e7\u00e3o satisfat\u00f3ria. O fabricante assina a Declara\u00e7\u00e3o de Conformidade da UE (Anexo IV). Marca CE + n\u00famero do organismo notificado afixados no dispositivo\/r\u00f3tulo. \u00c9 necess\u00e1ria a implementa\u00e7\u00e3o de um plano de notifica\u00e7\u00e3o de vigil\u00e2ncia e vigil\u00e2ncia p\u00f3s-comercializa\u00e7\u00e3o (PMS).<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Discrimina\u00e7\u00e3o dos custos da marca\u00e7\u00e3o CE<\/h3>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td class=\"has-text-align-left\" data-align=\"left\">Componente de custo<\/td><td class=\"has-text-align-left\" data-align=\"left\">Gama de custos<\/td><td class=\"has-text-align-left\" data-align=\"left\">Notas<\/td><\/tr><tr><td>Taxa do Organismo Notificado<\/td><td>\u20ac15,000-\u20ac50,000<\/td><td>Vari\u00e1vel por classe e complexidade<\/td><\/tr><tr><td>Documenta\u00e7\u00e3o t\u00e9cnica<\/td><td>\u20ac20,000-\u20ac60,000<\/td><td>Revis\u00e3o da literatura, an\u00e1lise de risco<\/td><\/tr><tr><td>Avalia\u00e7\u00e3o cl\u00ednica<\/td><td>\u20ac30,000-\u20ac100,000+<\/td><td>An\u00e1lise sistem\u00e1tica + dados de desempenho<\/td><\/tr><tr><td>Certifica\u00e7\u00e3o ISO 13485<\/td><td>\u20ac15,000-\u20ac40,000<\/td><td>Se ainda n\u00e3o estiver certificado<\/td><\/tr><tr><td>Consultoria em mat\u00e9ria de regulamenta\u00e7\u00e3o<\/td><td>\u20ac20,000-\u20ac60,000<\/td><td>Estrat\u00e9gia IVDR\/MDR, documenta\u00e7\u00e3o<\/td><\/tr><tr><td>Total Mediana<\/td><td>\u20ac120,000-\u20ac310,000<\/td><td>-<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p>Impacto dos per\u00edodos de transi\u00e7\u00e3o alargados: Dispositivos da classe D: prazo alargado at\u00e9 dezembro de 2027; dispositivos da classe C: dezembro de 2028; Classe B e Classe A est\u00e9ril: dezembro de 2029. Os fabricantes podem adiar a transi\u00e7\u00e3o para o IVDR; os dispositivos IVDD antigos podem ser vendidos ao abrigo das disposi\u00e7\u00f5es transit\u00f3rias at\u00e9 2027-2029.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Compara\u00e7\u00e3o estrat\u00e9gica: Qual o primeiro caminho?<\/h2>\n\n\n\n<p>Hierarquia da linha do tempo (da mais r\u00e1pida para a mais lenta)<\/p>\n\n\n\n<ol start=\"1\" class=\"wp-block-list\">\n<li>FDA 510(k): 4-12 meses (o mais r\u00e1pido com um predicado forte)<\/li>\n\n\n\n<li>Marca\u00e7\u00e3o CE: 12-18 meses (depende da capacidade do Organismo Notificado)<\/li>\n<\/ol>\n\n\n\n<p>Hierarquia de custos (do mais baixo ao mais alto)<\/p>\n\n\n\n<ol start=\"1\" class=\"wp-block-list\">\n<li>FDA 510(k): $100,000-$500,000 (mediana $150-250k com consultoria)<\/li>\n\n\n\n<li>Marca\u00e7\u00e3o CE: 120 000 \u20ac - 310 000 \u20ac (~$130 000-$340 000 USD)<\/li>\n<\/ol>\n\n\n\n<h2 class=\"wp-block-heading\">Sequ\u00eancia de lan\u00e7amento global recomendada<\/h2>\n\n\n\n<p>Ano 1: Autoriza\u00e7\u00e3o da FDA 510(k) (mercado dos EUA)<\/p>\n\n\n\n<p>Justificativa: Cronograma mais r\u00e1pido; maior procura do mercado (mercado de analisadores hematol\u00f3gicos $2.1B); predicados abundantes; maior disponibilidade para pagar<\/p>\n\n\n\n<p>Custo: $150-250k tudo inclu\u00eddo<\/p>\n\n\n\n<p>Estrat\u00e9gia: Selecionar um predicado forte (Sysmex XN, Beckman Coulter DxH); concentrar-se em testes de bancada vs. ensaios cl\u00ednicos<\/p>\n\n\n\n<p>Resultados: Estabelecer a credibilidade da FDA; alavancar as aprova\u00e7\u00f5es subsequentes<\/p>\n\n\n\n<p>Ano 2: Marca\u00e7\u00e3o CE (mercado da UE)<\/p>\n\n\n\n<p>Fundamenta\u00e7\u00e3o: segundo mais r\u00e1pido; cen\u00e1rio de predicados da UE semelhante ao da FDA; oportunidade de mercado $1.2B<\/p>\n\n\n\n<p>Custo: $150-250k (reutilizar documenta\u00e7\u00e3o da FDA e dados cl\u00ednicos)<\/p>\n\n\n\n<p>Estrat\u00e9gia: Reutilizar a documenta\u00e7\u00e3o t\u00e9cnica da FDA; real\u00e7ar a credibilidade da autoriza\u00e7\u00e3o da FDA existente<\/p>\n\n\n\n<p>Cronograma: Apresentar no primeiro trimestre; espera-se aprova\u00e7\u00e3o no terceiro e quarto trimestres<\/p>\n\n\n\n<p>Resultado: Aceder aos mercados da UE, do Reino Unido e da ASEAN atrav\u00e9s da harmoniza\u00e7\u00e3o regulamentar<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Compara\u00e7\u00e3o dos requisitos de evid\u00eancia cl\u00ednica<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td class=\"has-text-align-left\" data-align=\"left\">Tipo de prova<\/td><td class=\"has-text-align-left\" data-align=\"left\">FDA 510(k)<\/td><td class=\"has-text-align-left\" data-align=\"left\">Marca CE (IVDR)<\/td><\/tr><tr><td>Dispositivo de predicado<\/td><td>Exigido (equival\u00eancia substancial)<\/td><td>N\u00e3o \u00e9 necess\u00e1rio<\/td><\/tr><tr><td>Ensaios cl\u00ednicos<\/td><td>Normalmente evitado<\/td><td>Normalmente evitado (classe C)<\/td><\/tr><tr><td>Literatura publicada<\/td><td>Extensivamente utilizado<\/td><td>Revis\u00e3o sistem\u00e1tica (Anexo XIV)<\/td><\/tr><tr><td>Teste de bancada<\/td><td>Biocompatibilidade, software, desempenho<\/td><td>Documenta\u00e7\u00e3o ISO 13485<\/td><\/tr><tr><td>Valida\u00e7\u00e3o anal\u00edtica<\/td><td>Compara\u00e7\u00e3o com m\u00e9todos de refer\u00eancia<\/td><td>Avalia\u00e7\u00e3o do desempenho<\/td><\/tr><tr><td>Dados cl\u00ednicos do mundo real<\/td><td>Apenas para reivindica\u00e7\u00f5es novas<\/td><td>Exigido sistematicamente (Anexo XIV)<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p>Principais conclus\u00f5es: Todas as vias est\u00e3o a avan\u00e7ar para a evid\u00eancia cl\u00ednica em vez dos ensaios. A FDA utiliza o predicado como substituto; a IVDR utiliza a revis\u00e3o sistem\u00e1tica da literatura. Ambas aceitam cada vez mais dados publicados sobre dispositivos predicados em vez de exigirem novos estudos cl\u00ednicos dispendiosos.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Conformidade p\u00f3s-aprova\u00e7\u00e3o e gest\u00e3o de altera\u00e7\u00f5es<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\">P\u00f3s-aprova\u00e7\u00e3o da FDA<\/h3>\n\n\n\n<p>Actualiza\u00e7\u00f5es anuais da lista de registo; pequenas altera\u00e7\u00f5es de conce\u00e7\u00e3o atrav\u00e9s da via suplementar 510(k) (60-90 dias); grandes altera\u00e7\u00f5es que exigem uma nova via 510(k) ou PMA; comunica\u00e7\u00e3o obrigat\u00f3ria de eventos adversos MedWatch (15 dias para eventos graves); vigil\u00e2ncia p\u00f3s-comercializa\u00e7\u00e3o, se exigido pela classe do dispositivo.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Marca CE p\u00f3s-aprova\u00e7\u00e3o<\/h3>\n\n\n\n<p>Notifica\u00e7\u00e3o de vigil\u00e2ncia: incidentes graves no prazo de 30 dias; n\u00e3o graves anualmente; vigil\u00e2ncia p\u00f3s-comercializa\u00e7\u00e3o obrigat\u00f3ria de acordo com o Anexo XV da Diretiva relativa aos medicamentos para uso humano; as altera\u00e7\u00f5es de conce\u00e7\u00e3o podem exigir uma reavalia\u00e7\u00e3o do organismo notificado (3-6 meses); \u00e9 necess\u00e1ria uma atualiza\u00e7\u00e3o anual da seguran\u00e7a.<\/p>\n\n\n\n<p>Custo anual de manuten\u00e7\u00e3o regulamentar: Or\u00e7amento $30,000-50,000 por regi\u00e3o para conformidade, relat\u00f3rios de seguran\u00e7a e gest\u00e3o de altera\u00e7\u00f5es de projeto.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">2026 Actualiza\u00e7\u00f5es regulamentares e tend\u00eancias emergentes<\/h2>\n\n\n\n<p>Perspectivas da FDA para 2026<\/p>\n\n\n\n<p>As restri\u00e7\u00f5es de pessoal podem prolongar os prazos de 510(k) para al\u00e9m do objetivo de 90 dias. O foco na valida\u00e7\u00e3o de software est\u00e1 a aumentar para a avalia\u00e7\u00e3o da ciberseguran\u00e7a dos dispositivos ligados \u00e0 nuvem. Dispositivos de IA\/ML que exigem valida\u00e7\u00e3o algor\u00edtmica e monitoriza\u00e7\u00e3o do desempenho (particularmente relevante para analisadores de CBC alimentados por IA).<\/p>\n\n\n\n<p>Actualiza\u00e7\u00f5es da IVDR 2026<\/p>\n\n\n\n<p>Per\u00edodos de transi\u00e7\u00e3o alargados: Classe D at\u00e9 dezembro de 2027; Classe C at\u00e9 dezembro de 2028. Persiste a crise de capacidade dos organismos notificados, com apenas 4 organismos designados. Proposta de MDR\/IVDR simplificado (janeiro de 2025) com prov\u00e1vel implementa\u00e7\u00e3o a partir de 2027.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Conclus\u00e3o e quadro de decis\u00e3o<\/h2>\n\n\n\n<p>Cinco quest\u00f5es cr\u00edticas para os fabricantes de CBC:<\/p>\n\n\n\n<ol start=\"1\" class=\"wp-block-list\">\n<li>Qual \u00e9 o seu principal mercado-alvo? (EUA = primeiro a FDA; UE = primeiro a marca CE)<\/li>\n\n\n\n<li>Existem dispositivos de refer\u00eancia s\u00f3lidos? (Sim = otimizar a estrat\u00e9gia; N\u00e3o = or\u00e7amento para provas cl\u00ednicas)<\/li>\n\n\n\n<li>O seu dispositivo \u00e9 alimentado por IA\/intensivo em termos de software? (Sim = prolongar o prazo 20-30% para valida\u00e7\u00e3o do algoritmo)<\/li>\n\n\n\n<li>Qual \u00e9 a sua press\u00e3o em termos de calend\u00e1rio? (Urgente = EUA primeiro; Estrat\u00e9gico = apresenta\u00e7\u00f5es paralelas Ano 2-3)<\/li>\n\n\n\n<li>Pode suportar um roteiro regulamentar de 2-3 anos? (N\u00e3o = concentra\u00e7\u00e3o num \u00fanico mercado; Sim = apresenta\u00e7\u00f5es paralelas para reduzir o tempo de ciclo)<\/li>\n<\/ol>\n\n\n\n<p>Recomenda\u00e7\u00e3o final: Para obter o m\u00e1ximo impacto no mercado com um risco razo\u00e1vel, procure obter a autoriza\u00e7\u00e3o da FDA 510(k) no Ano 1 (4-12 meses) e depois a Marca\u00e7\u00e3o CE no Ano 2 (12-18 meses). Esta sequ\u00eancia estabelece progressivamente a credibilidade, permite a reutiliza\u00e7\u00e3o da documenta\u00e7\u00e3o e posiciona o seu analisador de CBC para a lideran\u00e7a do mercado global.<\/p>\n\n\n\n<p>Os fornecedores de m\u00e1quinas CBC que procuram navegar por estes caminhos com orienta\u00e7\u00e3o especializada podem aproveitar a experi\u00eancia regulamentar global da Ozelle, que abrange as certifica\u00e7\u00f5es FDA 510(k), CE Mark e locais - permitindo que os fabricantes lancem estrategicamente no prazo mais r\u00e1pido poss\u00edvel.<\/p>\n\n\n\n<p>Para obter mais informa\u00e7\u00f5es sobre solu\u00e7\u00f5es de analisadores de hematologia e suporte regulamentar, visite <a href=\"https:\/\/ozellemed.com\/pt\/\">https:\/\/ozellemed.com\/en\/<\/a>.<\/p>","protected":false},"excerpt":{"rendered":"<p>Regulatory approval is essential but structurally different across the US and EU for CBC analyzer suppliers. The FDA&#8217;s 510(k) pathway and EU&#8217;s IVDR CE marking system employ distinct procedural architectures, evidence requirements, and governance models\u2014not simply varying speeds for the same goal. FDA 510(k) achieves clearance via predicate-device equivalence in 4\u201312 months (if strong predicates [&hellip;]<\/p>","protected":false},"author":42,"featured_media":8602,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[24],"tags":[],"class_list":["post-8322","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-24"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v25.8 (Yoast SEO v25.8) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>FDA vs CE Mark: Your Complete Regulatory Pathway for CBC Analyzer Approval<\/title>\n<meta name=\"description\" content=\"Compare FDA 510(k) clearance and CE marking (IVDR Class C\/D) pathways for hematology analyzers. Understand distinct procedural architectures, timelines, evidence frameworks, and strategic market entry sequencing for CBC machine suppliers\u2014not a simple speed comparison.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ozellemed.com\/pt\/fda-510k-and-ce-mark-ivdr-for-cbc-analyzers-two-distinct-regulatory-systems-how-to-navigate-both\/\" \/>\n<meta property=\"og:locale\" content=\"pt_PT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FDA 510(k) and CE Mark (IVDR) for CBC Analyzers: Two Distinct Regulatory Systems\u2014How to Navigate Both\" \/>\n<meta property=\"og:description\" content=\"Compare FDA 510(k) clearance and CE marking (IVDR Class C\/D) pathways for hematology analyzers. Understand distinct procedural architectures, timelines, evidence frameworks, and strategic market entry sequencing for CBC machine suppliers\u2014not a simple speed comparison.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ozellemed.com\/pt\/fda-510k-and-ce-mark-ivdr-for-cbc-analyzers-two-distinct-regulatory-systems-how-to-navigate-both\/\" \/>\n<meta property=\"og:site_name\" content=\"Ozelle\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/people\/Ozelle\/61554405117096\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-23T12:29:07+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-30T16:45:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ozellemed.com\/wp-content\/uploads\/2026\/01\/Blog\u5c01\u9762\u56fe-1-2.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"720\" \/>\n\t<meta property=\"og:image:height\" content=\"476\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"ozelleseo\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"ozelleseo\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo estimado de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"9 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ozellemed.com\/fda-510k-and-ce-mark-ivdr-for-cbc-analyzers-two-distinct-regulatory-systems-how-to-navigate-both\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ozellemed.com\/fda-510k-and-ce-mark-ivdr-for-cbc-analyzers-two-distinct-regulatory-systems-how-to-navigate-both\/\"},\"author\":{\"name\":\"ozelleseo\",\"@id\":\"https:\/\/ozellemed.com\/ar\/#\/schema\/person\/4d04066026c5abe7e14052a2af533c7b\"},\"headline\":\"FDA 510(k) and CE Mark (IVDR) for CBC Analyzers: Two Distinct Regulatory Systems\u2014How to Navigate Both\",\"datePublished\":\"2026-01-23T12:29:07+00:00\",\"dateModified\":\"2026-01-30T16:45:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ozellemed.com\/fda-510k-and-ce-mark-ivdr-for-cbc-analyzers-two-distinct-regulatory-systems-how-to-navigate-both\/\"},\"wordCount\":1448,\"publisher\":{\"@id\":\"https:\/\/ozellemed.com\/ar\/#organization\"},\"image\":{\"@id\":\"https:\/\/ozellemed.com\/fda-510k-and-ce-mark-ivdr-for-cbc-analyzers-two-distinct-regulatory-systems-how-to-navigate-both\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ozellemed.com\/wp-content\/uploads\/2026\/01\/Blog\u5c01\u9762\u56fe-1-2.webp\",\"articleSection\":[\"Blogs\"],\"inLanguage\":\"pt-PT\",\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\/\/ozellemed.com\/pt\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ozellemed.com\/fda-510k-and-ce-mark-ivdr-for-cbc-analyzers-two-distinct-regulatory-systems-how-to-navigate-both\/\",\"url\":\"https:\/\/ozellemed.com\/fda-510k-and-ce-mark-ivdr-for-cbc-analyzers-two-distinct-regulatory-systems-how-to-navigate-both\/\",\"name\":\"FDA vs CE Mark: Your Complete Regulatory Pathway for CBC Analyzer Approval\",\"isPartOf\":{\"@id\":\"https:\/\/ozellemed.com\/ar\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ozellemed.com\/fda-510k-and-ce-mark-ivdr-for-cbc-analyzers-two-distinct-regulatory-systems-how-to-navigate-both\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ozellemed.com\/fda-510k-and-ce-mark-ivdr-for-cbc-analyzers-two-distinct-regulatory-systems-how-to-navigate-both\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ozellemed.com\/wp-content\/uploads\/2026\/01\/Blog\u5c01\u9762\u56fe-1-2.webp\",\"datePublished\":\"2026-01-23T12:29:07+00:00\",\"dateModified\":\"2026-01-30T16:45:00+00:00\",\"description\":\"Compare FDA 510(k) clearance and CE marking (IVDR Class C\/D) pathways for hematology analyzers. Understand distinct procedural architectures, timelines, evidence frameworks, and strategic market entry sequencing for CBC machine suppliers\u2014not a simple speed comparison.\",\"breadcrumb\":{\"@id\":\"https:\/\/ozellemed.com\/fda-510k-and-ce-mark-ivdr-for-cbc-analyzers-two-distinct-regulatory-systems-how-to-navigate-both\/#breadcrumb\"},\"inLanguage\":\"pt-PT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ozellemed.com\/fda-510k-and-ce-mark-ivdr-for-cbc-analyzers-two-distinct-regulatory-systems-how-to-navigate-both\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-PT\",\"@id\":\"https:\/\/ozellemed.com\/fda-510k-and-ce-mark-ivdr-for-cbc-analyzers-two-distinct-regulatory-systems-how-to-navigate-both\/#primaryimage\",\"url\":\"https:\/\/ozellemed.com\/wp-content\/uploads\/2026\/01\/Blog\u5c01\u9762\u56fe-1-2.webp\",\"contentUrl\":\"https:\/\/ozellemed.com\/wp-content\/uploads\/2026\/01\/Blog\u5c01\u9762\u56fe-1-2.webp\",\"width\":720,\"height\":476},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ozellemed.com\/fda-510k-and-ce-mark-ivdr-for-cbc-analyzers-two-distinct-regulatory-systems-how-to-navigate-both\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ozellemed.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FDA 510(k) and CE Mark (IVDR) for CBC Analyzers: Two Distinct Regulatory Systems\u2014How to Navigate Both\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ozellemed.com\/ar\/#website\",\"url\":\"https:\/\/ozellemed.com\/ar\/\",\"name\":\"Ozelle\",\"description\":\"Advanced IVD Medical Devices for Accurate Diagnostics\",\"publisher\":{\"@id\":\"https:\/\/ozellemed.com\/ar\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ozellemed.com\/ar\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-PT\"},{\"@type\":[\"Organization\",\"Place\"],\"@id\":\"https:\/\/ozellemed.com\/ar\/#organization\",\"name\":\"Ozelle\",\"url\":\"https:\/\/ozellemed.com\/ar\/\",\"logo\":{\"@id\":\"https:\/\/ozellemed.com\/fda-510k-and-ce-mark-ivdr-for-cbc-analyzers-two-distinct-regulatory-systems-how-to-navigate-both\/#local-main-organization-logo\"},\"image\":{\"@id\":\"https:\/\/ozellemed.com\/fda-510k-and-ce-mark-ivdr-for-cbc-analyzers-two-distinct-regulatory-systems-how-to-navigate-both\/#local-main-organization-logo\"},\"sameAs\":[\"https:\/\/www.facebook.com\/people\/Ozelle\/61554405117096\/\",\"https:\/\/linkedin.com\/company\/ehome-health\/?viewAsMember=true\",\"https:\/\/www.youtube.com\/channel\/UC9aRrEh8r7gb3iX3vPvbHGw\",\"https:\/\/www.pinterest.com\/ozellegmbh\/\"],\"telephone\":[],\"openingHoursSpecification\":{\"@type\":\"OpeningHoursSpecification\",\"dayOfWeek\":[\"Monday\",\"Tuesday\",\"Wednesday\",\"Thursday\",\"Friday\",\"Saturday\",\"Sunday\"],\"opens\":\"00:00\",\"closes\":\"23:59\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ozellemed.com\/ar\/#\/schema\/person\/4d04066026c5abe7e14052a2af533c7b\",\"name\":\"ozelleseo\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-PT\",\"@id\":\"https:\/\/ozellemed.com\/ar\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/60a8afaabb6286998aef954d019e3f7e597f10b61132433fefa96ce4fc916b17\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/60a8afaabb6286998aef954d019e3f7e597f10b61132433fefa96ce4fc916b17\",\"caption\":\"ozelleseo\"},\"url\":\"https:\/\/ozellemed.com\/pt\/author\/ozelleseo\/\"},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-PT\",\"@id\":\"https:\/\/ozellemed.com\/fda-510k-and-ce-mark-ivdr-for-cbc-analyzers-two-distinct-regulatory-systems-how-to-navigate-both\/#local-main-organization-logo\",\"url\":\"https:\/\/ozellemed.com\/wp-content\/uploads\/2025\/09\/cropped-logo-1.png\",\"contentUrl\":\"https:\/\/ozellemed.com\/wp-content\/uploads\/2025\/09\/cropped-logo-1.png\",\"width\":180,\"height\":80,\"caption\":\"Ozelle\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"FDA vs. Marca CE: O seu percurso regulamentar completo para a aprova\u00e7\u00e3o do analisador de CBC","description":"Comparar as vias de autoriza\u00e7\u00e3o da FDA 510(k) e de marca\u00e7\u00e3o CE (IVDR Classe C\/D) para analisadores de hematologia. Compreender arquitecturas processuais distintas, prazos, quadros de provas e sequ\u00eancias estrat\u00e9gicas de entrada no mercado para fornecedores de m\u00e1quinas de hemograma - n\u00e3o uma simples compara\u00e7\u00e3o de velocidade.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ozellemed.com\/pt\/fda-510k-and-ce-mark-ivdr-for-cbc-analyzers-two-distinct-regulatory-systems-how-to-navigate-both\/","og_locale":"pt_PT","og_type":"article","og_title":"FDA 510(k) and CE Mark (IVDR) for CBC Analyzers: Two Distinct Regulatory Systems\u2014How to Navigate Both","og_description":"Compare FDA 510(k) clearance and CE marking (IVDR Class C\/D) pathways for hematology analyzers. Understand distinct procedural architectures, timelines, evidence frameworks, and strategic market entry sequencing for CBC machine suppliers\u2014not a simple speed comparison.","og_url":"https:\/\/ozellemed.com\/pt\/fda-510k-and-ce-mark-ivdr-for-cbc-analyzers-two-distinct-regulatory-systems-how-to-navigate-both\/","og_site_name":"Ozelle","article_publisher":"https:\/\/www.facebook.com\/people\/Ozelle\/61554405117096\/","article_published_time":"2026-01-23T12:29:07+00:00","article_modified_time":"2026-01-30T16:45:00+00:00","og_image":[{"width":720,"height":476,"url":"https:\/\/ozellemed.com\/wp-content\/uploads\/2026\/01\/Blog\u5c01\u9762\u56fe-1-2.webp","type":"image\/webp"}],"author":"ozelleseo","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"ozelleseo","Tempo estimado de leitura":"9 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ozellemed.com\/fda-510k-and-ce-mark-ivdr-for-cbc-analyzers-two-distinct-regulatory-systems-how-to-navigate-both\/#article","isPartOf":{"@id":"https:\/\/ozellemed.com\/fda-510k-and-ce-mark-ivdr-for-cbc-analyzers-two-distinct-regulatory-systems-how-to-navigate-both\/"},"author":{"name":"ozelleseo","@id":"https:\/\/ozellemed.com\/ar\/#\/schema\/person\/4d04066026c5abe7e14052a2af533c7b"},"headline":"FDA 510(k) and CE Mark (IVDR) for CBC Analyzers: Two Distinct Regulatory Systems\u2014How to Navigate Both","datePublished":"2026-01-23T12:29:07+00:00","dateModified":"2026-01-30T16:45:00+00:00","mainEntityOfPage":{"@id":"https:\/\/ozellemed.com\/fda-510k-and-ce-mark-ivdr-for-cbc-analyzers-two-distinct-regulatory-systems-how-to-navigate-both\/"},"wordCount":1448,"publisher":{"@id":"https:\/\/ozellemed.com\/ar\/#organization"},"image":{"@id":"https:\/\/ozellemed.com\/fda-510k-and-ce-mark-ivdr-for-cbc-analyzers-two-distinct-regulatory-systems-how-to-navigate-both\/#primaryimage"},"thumbnailUrl":"https:\/\/ozellemed.com\/wp-content\/uploads\/2026\/01\/Blog\u5c01\u9762\u56fe-1-2.webp","articleSection":["Blogs"],"inLanguage":"pt-PT","copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/ozellemed.com\/pt\/#organization"}},{"@type":"WebPage","@id":"https:\/\/ozellemed.com\/fda-510k-and-ce-mark-ivdr-for-cbc-analyzers-two-distinct-regulatory-systems-how-to-navigate-both\/","url":"https:\/\/ozellemed.com\/fda-510k-and-ce-mark-ivdr-for-cbc-analyzers-two-distinct-regulatory-systems-how-to-navigate-both\/","name":"FDA vs. Marca CE: O seu percurso regulamentar completo para a aprova\u00e7\u00e3o do analisador de CBC","isPartOf":{"@id":"https:\/\/ozellemed.com\/ar\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ozellemed.com\/fda-510k-and-ce-mark-ivdr-for-cbc-analyzers-two-distinct-regulatory-systems-how-to-navigate-both\/#primaryimage"},"image":{"@id":"https:\/\/ozellemed.com\/fda-510k-and-ce-mark-ivdr-for-cbc-analyzers-two-distinct-regulatory-systems-how-to-navigate-both\/#primaryimage"},"thumbnailUrl":"https:\/\/ozellemed.com\/wp-content\/uploads\/2026\/01\/Blog\u5c01\u9762\u56fe-1-2.webp","datePublished":"2026-01-23T12:29:07+00:00","dateModified":"2026-01-30T16:45:00+00:00","description":"Comparar as vias de autoriza\u00e7\u00e3o da FDA 510(k) e de marca\u00e7\u00e3o CE (IVDR Classe C\/D) para analisadores de hematologia. Compreender arquitecturas processuais distintas, prazos, quadros de provas e sequ\u00eancias estrat\u00e9gicas de entrada no mercado para fornecedores de m\u00e1quinas de hemograma - n\u00e3o uma simples compara\u00e7\u00e3o de velocidade.","breadcrumb":{"@id":"https:\/\/ozellemed.com\/fda-510k-and-ce-mark-ivdr-for-cbc-analyzers-two-distinct-regulatory-systems-how-to-navigate-both\/#breadcrumb"},"inLanguage":"pt-PT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ozellemed.com\/fda-510k-and-ce-mark-ivdr-for-cbc-analyzers-two-distinct-regulatory-systems-how-to-navigate-both\/"]}]},{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/ozellemed.com\/fda-510k-and-ce-mark-ivdr-for-cbc-analyzers-two-distinct-regulatory-systems-how-to-navigate-both\/#primaryimage","url":"https:\/\/ozellemed.com\/wp-content\/uploads\/2026\/01\/Blog\u5c01\u9762\u56fe-1-2.webp","contentUrl":"https:\/\/ozellemed.com\/wp-content\/uploads\/2026\/01\/Blog\u5c01\u9762\u56fe-1-2.webp","width":720,"height":476},{"@type":"BreadcrumbList","@id":"https:\/\/ozellemed.com\/fda-510k-and-ce-mark-ivdr-for-cbc-analyzers-two-distinct-regulatory-systems-how-to-navigate-both\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ozellemed.com\/"},{"@type":"ListItem","position":2,"name":"FDA 510(k) and CE Mark (IVDR) for CBC Analyzers: Two Distinct Regulatory Systems\u2014How to Navigate Both"}]},{"@type":"WebSite","@id":"https:\/\/ozellemed.com\/ar\/#website","url":"https:\/\/ozellemed.com\/ar\/","name":"Ozelle","description":"Dispositivos m\u00e9dicos avan\u00e7ados IVD para diagn\u00f3sticos precisos","publisher":{"@id":"https:\/\/ozellemed.com\/ar\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ozellemed.com\/ar\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-PT"},{"@type":["Organization","Place"],"@id":"https:\/\/ozellemed.com\/ar\/#organization","name":"Ozelle","url":"https:\/\/ozellemed.com\/ar\/","logo":{"@id":"https:\/\/ozellemed.com\/fda-510k-and-ce-mark-ivdr-for-cbc-analyzers-two-distinct-regulatory-systems-how-to-navigate-both\/#local-main-organization-logo"},"image":{"@id":"https:\/\/ozellemed.com\/fda-510k-and-ce-mark-ivdr-for-cbc-analyzers-two-distinct-regulatory-systems-how-to-navigate-both\/#local-main-organization-logo"},"sameAs":["https:\/\/www.facebook.com\/people\/Ozelle\/61554405117096\/","https:\/\/linkedin.com\/company\/ehome-health\/?viewAsMember=true","https:\/\/www.youtube.com\/channel\/UC9aRrEh8r7gb3iX3vPvbHGw","https:\/\/www.pinterest.com\/ozellegmbh\/"],"telephone":[],"openingHoursSpecification":{"@type":"OpeningHoursSpecification","dayOfWeek":["Monday","Tuesday","Wednesday","Thursday","Friday","Saturday","Sunday"],"opens":"00:00","closes":"23:59"}},{"@type":"Person","@id":"https:\/\/ozellemed.com\/ar\/#\/schema\/person\/4d04066026c5abe7e14052a2af533c7b","name":"ozeleseo","image":{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/ozellemed.com\/ar\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/60a8afaabb6286998aef954d019e3f7e597f10b61132433fefa96ce4fc916b17","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/60a8afaabb6286998aef954d019e3f7e597f10b61132433fefa96ce4fc916b17","caption":"ozelleseo"},"url":"https:\/\/ozellemed.com\/pt\/author\/ozelleseo\/"},{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/ozellemed.com\/fda-510k-and-ce-mark-ivdr-for-cbc-analyzers-two-distinct-regulatory-systems-how-to-navigate-both\/#local-main-organization-logo","url":"https:\/\/ozellemed.com\/wp-content\/uploads\/2025\/09\/cropped-logo-1.png","contentUrl":"https:\/\/ozellemed.com\/wp-content\/uploads\/2025\/09\/cropped-logo-1.png","width":180,"height":80,"caption":"Ozelle"}]}},"_links":{"self":[{"href":"https:\/\/ozellemed.com\/pt\/wp-json\/wp\/v2\/posts\/8322","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ozellemed.com\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ozellemed.com\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ozellemed.com\/pt\/wp-json\/wp\/v2\/users\/42"}],"replies":[{"embeddable":true,"href":"https:\/\/ozellemed.com\/pt\/wp-json\/wp\/v2\/comments?post=8322"}],"version-history":[{"count":2,"href":"https:\/\/ozellemed.com\/pt\/wp-json\/wp\/v2\/posts\/8322\/revisions"}],"predecessor-version":[{"id":8330,"href":"https:\/\/ozellemed.com\/pt\/wp-json\/wp\/v2\/posts\/8322\/revisions\/8330"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ozellemed.com\/pt\/wp-json\/wp\/v2\/media\/8602"}],"wp:attachment":[{"href":"https:\/\/ozellemed.com\/pt\/wp-json\/wp\/v2\/media?parent=8322"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ozellemed.com\/pt\/wp-json\/wp\/v2\/categories?post=8322"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ozellemed.com\/pt\/wp-json\/wp\/v2\/tags?post=8322"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}